Drug Type Small molecule drug |
Synonyms Meclocycline, Meclocycline sulfosalicylate (USP), GS-2989 + [5] |
Target |
Action inhibitors |
Mechanism 30S subunit inhibitors(30S ribosomal subunit inhibitors) |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date United States (01 Jan 1982) |
Regulation- |
Molecular FormulaC29H27ClN2O14S |
InChIKeyFYSVKUUNXYGFLA-CCHMMTNSSA-N |
CAS Registry73816-42-9 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Acne Vulgaris | - | - | - |
| Skin Diseases, Infectious | - | - | - |
| Vaginitis | - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Stomatitis | Phase 2 | United States | - | |
| Stomatitis | Phase 2 | India | - |
Phase 2 | - | 81 | (SNX-1012) | nqtbdxamdm(slbtgalxwo) = iwmivaelpw jlralyyavm (lkgstxvnsp, 3.04) View more | - | 18 Mar 2009 | |
Placebo+SNX-1012 (Placebo) | nqtbdxamdm(slbtgalxwo) = rozobquflm jlralyyavm (lkgstxvnsp, 4.68) View more |





